PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Nirmidas Biotech Inc., Palo Alto, CA, USA.\', \'California Department of Public Health Viral and Rickettsia Disease Laboratory, Richmond, CA, USA.\', \'Dr Jack S. Remington Laboratory for Specialty Diagnostics, National Reference Center for the Study and Diagnosis of Toxoplasmosis, Palo Alto Medical Foundation, Palo Alto, CA, USA.\', \'Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, MD, USA.\', \'Dr Jack S. Remington Laboratory for Specialty Diagnostics, National Reference Center for the Study and Diagnosis of Toxoplasmosis, Palo Alto Medical Foundation, Palo Alto, CA, USA. montoyj@sutterhealth.org.\', \'Nirmidas Biotech Inc., Palo Alto, CA, USA. meijie.tang@nirmidas.com.\', \'Department of Chemistry and Bio-X, Stanford University, Stanford, CA, USA. hdai@stanford.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41551-020-00642-4
?:doi
?:hasPublicationType
?:journal
  • Nature biomedical engineering
is ?:pmid of
?:pmid
?:pmid
  • 33122853
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • 9
is ?:relation_isRelatedTo_publication of
?:title
  • Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33122853>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33122853>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all